Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301
We evaluated the frequency, demographic, clinical, disability evolution and genetic association of HLA DRB1*1501, DRB1*1503, DQA1*0102, DQB1*0602 and DPA1*0301 alleles in patients diagnosed as acute disseminated encephalomyelitis (ADEM) among a population of CNS demyelinating diseases. Fifteen patie...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
2009-09-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000400013 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849739114849501184 |
|---|---|
| author | Soniza Vieira Alves-Leon Maria Lucia Veluttini-Pimentel Maria Emmerick Gouveia Fabíola Rachid Malfetano Emerson L. Gaspareto Marcos P. Alvarenga Izabel Frugulhetti Thereza Quirico-Santos |
| author_facet | Soniza Vieira Alves-Leon Maria Lucia Veluttini-Pimentel Maria Emmerick Gouveia Fabíola Rachid Malfetano Emerson L. Gaspareto Marcos P. Alvarenga Izabel Frugulhetti Thereza Quirico-Santos |
| author_sort | Soniza Vieira Alves-Leon |
| collection | DOAJ |
| description | We evaluated the frequency, demographic, clinical, disability evolution and genetic association of HLA DRB1*1501, DRB1*1503, DQA1*0102, DQB1*0602 and DPA1*0301 alleles in patients diagnosed as acute disseminated encephalomyelitis (ADEM) among a population of CNS demyelinating diseases. Fifteen patients (8.4%) of our series were diagnosed as ADEM. The mean age onset was 35.23 years (range 12 to 77), 53.3% were male and follow-up range was 8.5 to 16 years. Two cases (13.3%) had a preceding infection before neurological symptoms, one presented a parainfectious demyelinating, and one case had been submitted to hepatitis B vaccination four weeks before the clinical onset. The EDSS range was 3.0 to 9.5. Eight patients (53.3%) presented MRI with multiple large lesions. CSF was normal in 73.3%. The severe disability observed at EDSS onset improved in 86.66% patients. The genetic susceptibility for ADEM was significantly associated with the HLA DQB1*0602, DRB1*1501 and DRB1*1503 alleles (<0.05) in monophasic ADEM.<br>Avaliamos as frequencia, características demográficas, clínicas e de associação genética dos alelos HLA DRB1*1501, DRB1*1503, DQA1*0102, DQB1*0602 e DPA1*0301 em pacientes com diagnóstico de encefalomielite aguda disseminada (ADEM) em população com doença desmielinizante do SNC. Quinze (8,4%) pacientes de nossa série foram diagnosticados como ADEM. A média de idade foi 35,23 anos (variando entre 12 e 77), 53,3% eram homens e o tempo de acompanhamento variou entre 8,5 e 16 anos. Dois casos (13,3%) apresentaram infecção prévia, um apresentou processo desmielinizante para infeccioso e outro havia se submetido a vacinação para hepatite B quatro semanas antes. O EDSS variou entre 3,0 e 9,5. Oito pacientes (53,3%) apresentaram grandes lesões na RM. O LCR foi normal em 73,3%. A incapacidade grave quantificada pelo EDSS foi seguida de melhora importante em 86,6% dos pacientes. A susceptibilidade genética na ADEM foi significativamente associada com os alelos HLA DQB1*0602, DRB1*1501 e DRB1*1503 (p<0,05) nos pacientes com quadro monofásico. |
| format | Article |
| id | doaj-art-eb31874773e54402b349d3f03b4457a8 |
| institution | DOAJ |
| issn | 0004-282X 1678-4227 |
| language | English |
| publishDate | 2009-09-01 |
| publisher | Thieme Revinter Publicações |
| record_format | Article |
| series | Arquivos de Neuro-Psiquiatria |
| spelling | doaj-art-eb31874773e54402b349d3f03b4457a82025-08-20T03:06:23ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria0004-282X1678-42272009-09-01673a64365110.1590/S0004-282X2009000400013Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301Soniza Vieira Alves-LeonMaria Lucia Veluttini-PimentelMaria Emmerick GouveiaFabíola Rachid MalfetanoEmerson L. GasparetoMarcos P. AlvarengaIzabel FrugulhettiThereza Quirico-SantosWe evaluated the frequency, demographic, clinical, disability evolution and genetic association of HLA DRB1*1501, DRB1*1503, DQA1*0102, DQB1*0602 and DPA1*0301 alleles in patients diagnosed as acute disseminated encephalomyelitis (ADEM) among a population of CNS demyelinating diseases. Fifteen patients (8.4%) of our series were diagnosed as ADEM. The mean age onset was 35.23 years (range 12 to 77), 53.3% were male and follow-up range was 8.5 to 16 years. Two cases (13.3%) had a preceding infection before neurological symptoms, one presented a parainfectious demyelinating, and one case had been submitted to hepatitis B vaccination four weeks before the clinical onset. The EDSS range was 3.0 to 9.5. Eight patients (53.3%) presented MRI with multiple large lesions. CSF was normal in 73.3%. The severe disability observed at EDSS onset improved in 86.66% patients. The genetic susceptibility for ADEM was significantly associated with the HLA DQB1*0602, DRB1*1501 and DRB1*1503 alleles (<0.05) in monophasic ADEM.<br>Avaliamos as frequencia, características demográficas, clínicas e de associação genética dos alelos HLA DRB1*1501, DRB1*1503, DQA1*0102, DQB1*0602 e DPA1*0301 em pacientes com diagnóstico de encefalomielite aguda disseminada (ADEM) em população com doença desmielinizante do SNC. Quinze (8,4%) pacientes de nossa série foram diagnosticados como ADEM. A média de idade foi 35,23 anos (variando entre 12 e 77), 53,3% eram homens e o tempo de acompanhamento variou entre 8,5 e 16 anos. Dois casos (13,3%) apresentaram infecção prévia, um apresentou processo desmielinizante para infeccioso e outro havia se submetido a vacinação para hepatite B quatro semanas antes. O EDSS variou entre 3,0 e 9,5. Oito pacientes (53,3%) apresentaram grandes lesões na RM. O LCR foi normal em 73,3%. A incapacidade grave quantificada pelo EDSS foi seguida de melhora importante em 86,6% dos pacientes. A susceptibilidade genética na ADEM foi significativamente associada com os alelos HLA DQB1*0602, DRB1*1501 e DRB1*1503 (p<0,05) nos pacientes com quadro monofásico.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000400013ADEMHLA classe IIdoenças desmielinizantesADEMHLA class IIdemyelinating disease |
| spellingShingle | Soniza Vieira Alves-Leon Maria Lucia Veluttini-Pimentel Maria Emmerick Gouveia Fabíola Rachid Malfetano Emerson L. Gaspareto Marcos P. Alvarenga Izabel Frugulhetti Thereza Quirico-Santos Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301 Arquivos de Neuro-Psiquiatria ADEM HLA classe II doenças desmielinizantes ADEM HLA class II demyelinating disease |
| title | Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301 |
| title_full | Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301 |
| title_fullStr | Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301 |
| title_full_unstemmed | Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301 |
| title_short | Acute disseminated encephalomyelitis: clinical features, HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602, and HLA DPA1*0301 allelic association study Encefalomielite aguda disseminada: características clínicas e estudo de associação com os alelos HLA DRB1*1501, HLA DRB1*1503, HLA DQA1*0102, HLA DQB1*0602 e DPA1*0301 |
| title_sort | acute disseminated encephalomyelitis clinical features hla drb1 1501 hla drb1 1503 hla dqa1 0102 hla dqb1 0602 and hla dpa1 0301 allelic association study encefalomielite aguda disseminada caracteristicas clinicas e estudo de associacao com os alelos hla drb1 1501 hla drb1 1503 hla dqa1 0102 hla dqb1 0602 e dpa1 0301 |
| topic | ADEM HLA classe II doenças desmielinizantes ADEM HLA class II demyelinating disease |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2009000400013 |
| work_keys_str_mv | AT sonizavieiraalvesleon acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT marialuciaveluttinipimentel acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT mariaemmerickgouveia acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT fabiolarachidmalfetano acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT emersonlgaspareto acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT marcospalvarenga acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT izabelfrugulhetti acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 AT therezaquiricosantos acutedisseminatedencephalomyelitisclinicalfeatureshladrb11501hladrb11503hladqa10102hladqb10602andhladpa10301allelicassociationstudyencefalomieliteagudadisseminadacaracteristicasclinicaseestudodeassociacaocomosaleloshladrb11501hladrb11503hladqa10102hladqb1 |